Evidence map›Paper›PMID 24802332›Full record

ArticleJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism2014

Role of microRNA29b in blood-brain barrier dysfunction during hyperhomocysteinemia: an epigenetic mechanism.

Anuradha Kalani, Pradip K Kamat, Anastasia Familtseva, Pankaj Chaturvedi, Nino Muradashvili, Nithya Narayanan, Suresh C Tyagi, Neetu Tyagi

Open access · bronzeAbstract read
In one paragraph

Article in Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 74 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. The Role of DNA Methylation in Stroke Recovery.International journal of molecular sciences · 2022
    Review
  10. Article
  11. Article
  12. Review
  13. International journal of molecular sciences · 2021
    Article
  14. Review
  15. Article
  16. Epigenetics in blood-brain barrier disruption.Fluids and barriers of the CNS · 2021
    Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Anuradha KalaniDepartment of Physiology and Biophysics, School of Medicine, University of Louisville, Louisville, Kentucky, USA.
Pradip K KamatDepartment of Physiology and Biophysics, School of Medicine, University of Louisville, Louisville, Kentucky, USA.
Anastasia FamiltsevaDepartment of Physiology and Biophysics, School of Medicine, University of Louisville, Louisville, Kentucky, USA.
Pankaj ChaturvediDepartment of Physiology and Biophysics, School of Medicine, University of Louisville, Louisville, Kentucky, USA.
Nino MuradashviliDepartment of Physiology and Biophysics, School of Medicine, University of Louisville, Louisville, Kentucky, USA.
Nithya NarayananDepartment of Physiology and Biophysics, School of Medicine, University of Louisville, Louisville, Kentucky, USA.
Suresh C TyagiDepartment of Physiology and Biophysics, School of Medicine, University of Louisville, Louisville, Kentucky, USA.
Neetu TyagiDepartment of Physiology and Biophysics, School of Medicine, University of Louisville, Louisville, Kentucky, USA.
University of Louisville · US

Funding

Mechanisms of Mitochondrial Dysfunction in Brain VasculatureR01HL107640 · NHLBI · UNIVERSITY OF LOUISVILLE · PI TYAGI, NEETU · 2012 to 2016
$1.8M
NHLBI NIH HHS HL107640NHLBI NIH HHS R01 HL107640
6 · The paper itself

Abstract

Although blood-brain barrier (BBB) integrity is maintained by the cross-talk of endothelial cells, junction proteins, and neurogliovascular network, the epigenetic mechanisms behind BBB permeability are largely unknown. We are reporting for the first time miR29b-mediated regulation of BBB, which is a novel mechanism underlying BBB integrity. We hypothesize that miR29b regulates BBB dysfunction by regulating DNMT3b, which consequently regulates the levels of metalloproteinases, that can eat up the membrane and junction proteins leading to leaky vasculature. In addition, 5'-azacytidine (5'-aza) was used to test its efficacy on BBB permeability. Blood-brain barrier disruption model was created by using homocysteine, and in the models miR29b was identified to be most affected, by using microRNA RT(2)-qPCR array. MiR29b mimics and inhibitors also confirmed that miR29b regulates the levels DNMT3b and MMP9. In hyperhomocysteinemic cystathionine-β-synthase deficient (CBS(+/-)) mice with high brain vessel permeability, miR29b levels were also high as compared with wild-type (WT) mice. Interestingly, 5'-aza improved BBB permeability by decreasing the expression of miR29b. In conclusion, our data suggested miR29b-mediated regulation of BBB dysfunction through DNMT3b and MMP9. It also potentiates the use of microRNAs as candidates for future epigenetic therapies in the improvement of BBB integrity.

Indexed as

AnimalsBlood-Brain BarrierBlotting, WesternCapillary PermeabilityDisease Models, AnimalDNA (Cytosine-5-)-MethyltransferasesDNA Methyltransferase 3BEpigenesis, GeneticFlow CytometryHyperhomocysteinemiaImmunohistochemistryMaleMatrix Metalloproteinase 9MiceMice, Inbred C57BLMice, KnockoutDNA (Cytosine-5-)-MethyltransferasesDNA Methyltransferase 3BMatrix Metalloproteinase 9MicroRNAsMIRN29 microRNA, mouseMmp9 protein, mouse

Identifiers

PMID24802332
PMCPMC4083388
OpenAlexW2022861886

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.